ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia
- PMID: 20220321
- PMCID: PMC2865220
- DOI: 10.1097/WAD.0b013e3181b4f736
ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia
Abstract
We compared the predictive value of cerebral perfusion as measured by arterial-spin labeling magnetic resonance imaging (ASL-MRI) with MRI-derived hippocampal volume for determining future cognitive and functional decline and subsequent conversion from mild cognitive impairment to dementia. Forty-eight mild cognitive impairment subjects received structural and ASL-MRI scans at baseline and clinical and neuropsychologic assessments annually. Thirteen subjects became demented during the period of longitudinal observation (2.7+/-1.0 y). Cox regression analyses suggest that baseline hippocampal volume [relative risk (RR)=0.99, P=0.004], baseline right inferior parietal (RR=0.64, P=0.01) and right middle frontal (RR=0.73, P=0.01) perfusion were associated with conversion to dementia. Results from linear mixed effects modeling suggest that baseline perfusion from the right precuneus predicted subsequent declines in Clinical Dementia Rating Sum of Boxes (P=0.002), Functional Activates Questionnaire (P=0.01), and selective attention (ie, Stroop switching, P=0.009) whereas baseline perfusion from the right middle frontal cortex predicted subsequent episodic memory decline (ie, total recognition discriminability score from the California Verbal Learning Test, P=0.03). These results suggest that hypoperfusion as detected by ASL-MRI can predict subsequent clinical, functional, and cognitive decline and may be useful for identifying candidates for future Alzheimer disease treatment trials.
Figures





Similar articles
-
Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI.Neurology. 2006 Oct 10;67(7):1215-20. doi: 10.1212/01.wnl.0000238163.71349.78. Neurology. 2006. PMID: 17030755 Free PMC article. Clinical Trial.
-
Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.J Alzheimers Dis. 2021;82(1):293-305. doi: 10.3233/JAD-210199. J Alzheimers Dis. 2021. PMID: 34024834 Free PMC article.
-
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.Radiology. 2005 Mar;234(3):851-9. doi: 10.1148/radiol.2343040197. Radiology. 2005. PMID: 15734937 Free PMC article.
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
Mapping of cerebral perfusion territories using territorial arterial spin labeling: techniques and clinical application.NMR Biomed. 2013 Aug;26(8):901-12. doi: 10.1002/nbm.2836. Epub 2012 Jul 15. NMR Biomed. 2013. PMID: 22807022 Review.
Cited by
-
Cerebral perfusion and the risk of cognitive decline and dementia in community dwelling older people.Cereb Circ Cogn Behav. 2022 Feb 20;3:100125. doi: 10.1016/j.cccb.2022.100125. eCollection 2022. Cereb Circ Cogn Behav. 2022. PMID: 36324415 Free PMC article.
-
Use of biomarkers in clinical trials of Alzheimer disease: from concept to application.Mol Diagn Ther. 2011 Dec 1;15(6):313-25. doi: 10.1007/BF03256467. Mol Diagn Ther. 2011. PMID: 22188635
-
Effect of 40 Hz light flicker on cognitive impairment and transcriptome of hippocampus in right unilateral common carotid artery occlusion mice.Sci Rep. 2023 Dec 4;13(1):21361. doi: 10.1038/s41598-023-48897-6. Sci Rep. 2023. PMID: 38049571 Free PMC article.
-
Regulating effect of CBF on memory in cognitively normal older adults with different ApoE genotype: the Alzheimer's Disease Neuroimaging Initiative (ADNI).Cogn Neurodyn. 2019 Dec;13(6):513-518. doi: 10.1007/s11571-019-09536-x. Epub 2019 May 11. Cogn Neurodyn. 2019. PMID: 31741688 Free PMC article.
-
High-resolution mapping of brain vasculature and its impairment in the hippocampus of Alzheimer's disease mice.Natl Sci Rev. 2019 Nov;6(6):1223-1238. doi: 10.1093/nsr/nwz124. Epub 2019 Aug 28. Natl Sci Rev. 2019. PMID: 34692000 Free PMC article.
References
-
- Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238–1248. - PubMed
-
- Kogure D, Matsuda H, Ohnishi T, et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med. 2000;41:1155–1162. - PubMed
-
- Johnson KA, Albert MS. Perfusion abnormalities in prodromal AD. Neurobiol Aging. 2000;21:289–292. - PubMed
-
- Encinas M, De Juan R, Marcos A, et al. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2003;30:1473–1480. - PubMed
-
- Chetelat G, Desgranges B, de la Sayette V, et al. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology. 2003;60:1374–1377. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical